Radiation Therapy

The radiation therapy channel covers all aspects of radiation oncology technology. Radiation therapy includes linear accelerators (LINAC), proton therapy, brachytherapy, image guided radiation therapy (IGRT), focused ultrasound, stereotactic body radiation therapy (SBRT), intensity modulated radiation therapy (IMRT), treatment planning systems and tomotherapy.

Here is a list of the Top 10 most read pieces of content on ITNonline.com from the month of December 2021.
Feature | Radiology Business | By Melinda Taschetta-Millane
Top 10: Most Read Radiology Technology Content in December 2021

Here is a list of the Top 10 most read pieces of content on ITNonline.com from the month of December 2021. This is based ...

Time December 23, 2021
arrow
Neurosurgeon Adam Robin, M.D., surgically implants a GammaTile device for the first time in Michigan. Image courtesy of Henry Ford Health System
News | Radiation Therapy
Henry Ford Health System First in Michigan to Implant Novel Therapy for Recurrent Brain Tumors

December 22, 2021 — Surgeons at Henry Ford Health System have treated a patient with a recurrent brain tumor by ...

Time December 22, 2021
arrow
 IBA (Ion Beam Applications S.A.), a world leader in particle accelerator technology and the world’s leading provider of proton therapy solutions for the treatment of cancer, today announces it has signed a contract for the installation of a Proteus ONE proton therapy solution with the New Mexico Cancer Center in Albuquerque, NM, USA.
News | Proton Therapy
IBA and New Mexico Cancer Center Sign Contract to Install a Proteus ONE

December 22, 2021 — IBA (Ion Beam Applications S.A.), a world leader in particle accelerator technology and the world’s ...

Time December 22, 2021
arrow
RayCare 5B features full user configurability of all workflow configuration settings, including the possibility to create advanced workflow automation, from the administrator’s workspace.
News | Radiation Oncology
RayCare 5B Provides Cancer Clinics with User Configurable Workflows for Radiation Therapy

December 22, 2021 — RayCare 5B features full user configurability of all workflow configuration settings, including the ...

Time December 22, 2021
arrow
Immunolight LLC, a clinical stage biopharmaceutical firm leading the way in advancing technologies to transform cancer treatment, announced today it is now recruiting patients for a phase 1 study of its X-PACT Cancer Treatment system in Breast, Melanoma, Sarcoma and Head and Neck Cancers, to be conducted at Duke University Medical Center.
News | Radiation Oncology
Immunolight, LLC Now Recruiting Patients for Phase 1 Trial of the X-PACT System in Solid Tumors

December 20, 2021 — Immunolight LLC, a clinical stage biopharmaceutical firm leading the way in advancing technologies ...

Time December 20, 2021
arrow
Mirion Technologies, Inc., a global provider of detection, measurement, analysis and monitoring solutions to the medical, nuclear, defense, and research end markets, today announced the signing of a definitive agreement to acquire Computerized Imaging Reference Systems, Inc. (“CIRS”), a leading provider of medical imaging and radiation therapy phantoms serving the medical industry.
News | Radiation Therapy
Mirion Technologies to Acquire Computerized Imaging Reference Systems

December 10, 2021 — Mirion Technologies, Inc., a global provider of detection, measurement, analysis and monitoring ...

Time December 10, 2021
arrow
RefleXion Medical Inc., a therapeutic oncology company, announced that the U.S. Food and Drug Administration (FDA) has granted the company Breakthrough Device Designation for its biology-guided radiotherapy (BgRT) for use in treating lung tumors.
News | Radiation Therapy
RefleXion Receives Breakthrough Device Designation for Lung Cancer Treatment

December 6, 2021 — RefleXion Medical Inc., a therapeutic oncology company, announced that the U.S. Food and Drug ...

Time December 06, 2021
arrow
CIRS specializes in the design, development and commercialization of tissue equivalent medical imaging and radiation therapy phantoms for the radiotherapy and radio-diagnostic markets.
News | Nuclear Imaging
Mirion Technologies Completes Acquisition of Computerized Imaging Reference Systems, Inc.

December 3, 2021 — Mirion Technologies, Inc., a global provider of detection, measurement, analysis and monitoring ...

Time December 03, 2021
arrow
Figure 1. Proportion of U.S. states offering equivalent early prioritization for COVID vaccination for patients with cancer and patients over the age of 65 as recommended by the Centers for Disease Control and Prevention.
News | Coronavirus (COVID-19)
Cancer Patients Overlooked in COVID-19 Vaccine Rollout

December 2, 2021 — Almost two-thirds of U.S. states failed to prioritize cancer patients for COVID-19 vaccinations ...

Time December 02, 2021
arrow
Videos | Radiation Therapy
VIDEO: Sedating Children With Movies Rather Than Drugs for Radiation Therapy

Jeffrey T. Chapman, a medical student at the University of Texas Southwestern Medical Center, Explains how watching ...

Time November 24, 2021
arrow
Videos | Radiopharmaceuticals and Tracers
VIDEO: Advances in Radiopharmaceutical Therapy

Ana Kiess, M.D., Ph.D., assistant professor of radiation oncology and molecular radiation sciences, Johns Hopkins ...

Time November 17, 2021
arrow
Videos | Radiation Therapy
VIDEO: Elekta Harmony Radiotherapy System Walk-around

The Elekta Harmony radiotherapy system gained FDA clearance in the summer of 2021 and was on display for the first time ...

Time November 17, 2021
arrow
Radiation can be a powerful cancer therapy, but it doesn’t work for everyone. A new study identifies tumor features linked with resistance to radiotherapy, an important advance toward developing individualized cancer treatments.
News | Radiation Therapy
Study Identifies Cancer Features That Could Guide Personalized Radiotherapy

November 17, 2021 — Radiation can be a powerful cancer therapy, but it doesn’t work for everyone. A new study identifies ...

Time November 17, 2021
arrow
Videos | Radiation Oncology
VIDEO: Example of an Ion Beam Radiotherapy Treatment System

This is a model of the Toshiba ion beam radiation therapy system at the American Society of Radiation Oncology (ASTRO) ...

Time November 16, 2021
arrow
A new Harvey L. Neiman Health Policy Institute study of nearly 800,000 men found that between 2011 and 2017 black patients were 24% less likely than white patients to have a prostate MRI after receiving an elevated (prostate-specific antigen) PSA score
News | Prostate Cancer
Black Patients 24% Less Likely than White Patients to Have a Prostate MRI After Receiving an Elevated PSA Score

November 16, 2021 — A new Harvey L. Neiman Health Policy Institute study of nearly 800,000 men found that between 2011 ...

Time November 16, 2021
arrow
Videos | Radiation Oncology
VIDEO: MRI-Linac and PSMA PET Imaging Technologies Aids Therapy at GenesisCare

Walter Curran, Jr. M.D., FACR, FASCO, GenesisCare global chief medical officer, discusses three technologies that are ...

Time November 16, 2021
arrow
Videos | Radiation Oncology
VIDEO: Example of a Multileaf Collimator (MLC) on a Radiotherapy System

This is an example of a multileaf collimator (MLC) on the Accuray Thomotherapy radiation therapy system at the American ...

Time November 16, 2021
arrow
Videos | Radiation Therapy
VIDEO: 4 Radiation Oncology Technologies to Watch

Anthony Zietman, M.D., interim chief, radiation oncology, Mass General Cancer Center, and former president of the ...

Time November 15, 2021
arrow
Videos | Radiation Therapy
VIDEO: Examples of Synthetic CT Datasets Made From MRI for Radiotherapy Treatment Planning

Siemens and Philips demonstrated examples of new imaging software to convert MRI datasets into synthetic computed ...

Time November 15, 2021
arrow
Prelude Corporation (PreludeDx), a leader in molecular diagnostics and precision medicine for early-stage breast cancer, announced that the American Medical Association (AMA) has issued a new, dedicated current procedural terminology (CPT) proprietary laboratory analyses (PLA) code for DCISionRT, the only test available to predict personalized recurrence risk and radiation therapy benefit for patients with ductal carcinoma in situ (DCIS).
News | Radiation Oncology
American Medical Association Grants PreludeDx a CPT PLA Code for Proprietary DCISionRT Test

November 12, 2021 — Prelude Corporation (PreludeDx), a leader in molecular diagnostics and precision medicine for early ...

Time November 12, 2021
arrow
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now